Fight for the right of vapers to be smoke-free



    Find out what we stand for in vaping.



    Help us win the fight and donate today.



    Learn about our fight save vape!



    Who are the members of the R2B Coalition?

What we stand for

The Right to be Smoke-Free Coalition is a non-profit, industry-led trade association of e-vapor businesses dedicated to promoting the interests of the industry by advocating for reasonable and responsible laws and regulations, and fighting for the right of vapers to be smoke-free.

The Right to be Smoke-Free Coalition works with expert legal counsel and the broader industry to develop comprehensive litigation strategies to challenge unlawful Federal and State Laws and Regulations. Our current activities and information will be updated periodically. To join the fight please contribute to become a member of the Coalition.

Our Coalition is positioned to enforce and defend the industry, and we need your help. Lawsuits of these nature are costly and we expect vigorous defense against our efforts. If you are an industry advocate, e-liquid producer, device manufacturer, vape shop owner or internet retailer that believes in responsible and appropriate regulations, you can join the Coalition or contribute to the cause.

Contribute to Become Member

To become a member of the R2B Smoke-Free Coalition and our fight for reasonable and responsible vaping laws and regulations, click here to make a financial contribution.


The Right to be Smoke-Free Coalition is a 501(c)(6) non-profit trade association organized under the laws of Washington, D.C. We are not a charitable organization. Your contribution allows you to become a member. All funds raised go toward litigation fees and related expenses. Please check with your tax advisor to determine the tax deductibility of any contributions 

Learn about our fight

Right To Be Smoke Free Coalition and E-Vapor Industry Trade Associations File Lawsuit Challenging FDA’s Deeming Regulation and the Tobacco Control Act

On behalf of the Right To Be Smoke Free Coalition and the entire e-vapor industry, yesterday Keller and Heckman LLP filed a Complaint in the U.S. District Court for the District of Columbia challenging portions of FDA’s Deeming Regulation and the Tobacco Control Act on various constitutional and administrative grounds. The named Plaintiffs in the lawsuit are:

  1. Right To Be Smoke Free Coalition (RSF –
  2. American E-Liquid Manufacturing Standards Association (AEMSA –
  3. American Vaping Association (AVA –
  4. Electronic Vaping Coalition of America (EVCA –
  5. Georgia Smoke Free Association (GSFA –
  6. Kentucky Vaping Retailers Association, Inc., d/b/a Kentucky Smoke Free Association (KSFA –
  7. Louisiana Vaping Association (LAVA)
  8. Maryland Vape Professionals, LLC (
  9. Ohio Vapor Trade Association (OHVTA –
  10. New Jersey Vapor Retailers Coalition (NJVRC –
  11. Tennessee Smoke Free Association (TSFA –

Also supporting the lawsuit are the Shenzhen E-Vapor Industry Association USA (SEVIA-USA, the Smoke-Free Alternatives Trade Association (SFATA –, the Consumer Advocates for Smoke-free Alternatives Association (CASAA – and NOT Blowing Smoke (

In the Complaint, the Industry argues the following:

(1) Count I – Violation of Administrative Procedure Act – Grandfather Date: FDA had the authority and the statutory duty to establish a new Grandfather Date for e-vapor products (defined as Electronic Nicotine Delivery Systems or ENDS) or apply its enforcement authority so that some ENDS manufacturers, including e-liquid companies, would have the opportunity to forego the Premarket Tobacco Application (PMTA) pathway and avail themselves of the option to submit Substantial Equivalence (SE) Reports. By not doing so, FDA violated the Administrative Procedures Act.

(2) Count II – Violation of Administrative Procedure Act – Pre-market Authorization Process: FDA was obligated to consider the continuum of risk of tobacco products and exercise flexible enforcement authority mandated by Congress, instead of implementing a “one-size-fits-all” regulatory regime treating ENDS the same as cigarettes and other harmful products and forcing ENDS manufacturers into the PMTA process, which will all but ban the entire e-liquid and device categories. Accordingly, FDA’s application of the PMTA process to ENDS products violates the Administrative Procedures Act.

(3) Count III – Violation of Due Process and Equal Protection Clauses – Tobacco Control Act: In the Tobacco Control Act, Congress made clear that different tobacco products present different risks and that FDA should exercise its enforcement authority in a flexible manner. But if, as FDA argues, the Agency is mandated to enforce a “one-size-fits-all” regime to all products, including less harmful ENDS, then Congress did not provide FDA with the necessary tools and regulatory flexibility to achieve the Tobacco Control Act’s stated goals, which include allowing newer and safer products to enter the market. As a result, the Tobacco Control Act is unconstitutional under the Due Process and Equal Protection Clauses.

(4) Count IV – Violation of First Amendment and Administrative Procedure Act – Ban on Free Samples: FDA does not have a substantial interest in prohibiting access to free samples of ENDS products by adult consumers – including taste testing e-liquids in vape shops. The complete ban on free samples does not directly advance the government’s interests. There were more narrow options available to FDA to advance their stated interest in preventing youth access while still allowing vape shops and others to market using free samples. Accordingly, the total ban on free samples violates the First Amendment and the Administrative Procedures Act.

(5) Count V – Violation of First Amendment and Administrative Procedure Act – Modified Risk Tobacco Products: The Modified Risk Tobacco Product (MRTP) provision of the Tobacco Control Act as applied to ENDS products – which do not produce smoke, combust e-liquid when used as intended, or produce aerosol that contains the harmful substances found in tobacco smoke – does not advance any purported government interests (which focus on traditional tobacco products), and captures commercial and non-commercial speech that is clearly not misleading (e.g., “smoke free” claims). By applying the MRTP provision and its extensive review process to ENDS products, FDA violated the Administrative Procedures Act and the prior restraint doctrine.

(6) Count VI – Violation of Administrative Procedure Act – Definition of “Tobacco Product” and Application to ENDS: FDA considers a broad range of ENDS products to be regulated as tobacco products or “components or parts,” including, among other things, software that operates devices, batteries, displays, tanks, etc. FDA intends to regulate these products as tobacco products despite the fact that they do not contain tobacco, are not derived from tobacco and are not components and parts of an actual tobacco product. There is nothing in the legislative history of the Act, and FDA has provided no supporting rationale, for why these items should be regulated as tobacco products merely because they are used to consume the product. Accordingly, FDA’s application of the Tobacco Control Act’s definition of “tobacco product” to certain ENDS products is unreasonable and unlawful under the Administrative Procedures Act.

(7) Count VII – Violation of Regulatory Flexibility Act – Unlawful Cost/Benefit Analysis: The Regulatory Flexibility Act requires administrative agencies to consider the effects of their regulatory actions on small business entities. FDA failed to consider significant alternatives, including, but not limited to, the impact of any compliance period on the ability of small entities to successfully navigate the PMTA process given that FDA concedes that there are no long-term clinical studies or other data necessary to support such applications. FDA only considered several, modest alternatives focused on discrete issues (i.e., labeling burdens). The Agency did not make a reasonable, good faith effort to consider alternatives that would have an overall impact on all small entities. In short, FDA substantially overestimates the benefits of the Deeming Rule and underestimates the costs. Accordingly, the Court should take corrective action, set aside and remand the Deeming Rule to FDA, and defer enforcement until the Agency complies with the Regulatory Flexibility Act.

(8) Count VIII – Violation of Administrative Procedure Act – Unlawful Cost/Benefit Analysis:The Tobacco Control Act makes clear that FDA was required to adequately consider the costs and benefits of the Deeming Rule. As with the Regulatory Flexibility Act, FDA failed to consider regulatory alternatives, such as an extended compliance period, that would have significantly increased the chance that ENDS manufacturers would be able to comply with the PMTA process, thus avoiding what will be close to an effective ban on ENDS. The Agency also failed to properly estimate key factors necessary to an adequate cost/benefit analysis, including the number of entities and products affected, as well as the number of PMTA applications that will be filed. For many of these numbers, FDA did not adequately explain or support its conclusions. Again,FDA substantially overestimates the benefits of the Deeming Rule and underestimates the costs. As a result, FDA violated the Administrative Procedures Act and, therefore, the Deeming Rule must be remanded to the Agency so that a proper cost/benefit analysis may be conducted.

For more information on the lawsuit and updates, visit To learn more about Keller and Heckman’s e-vapor practice, visit

The State of Indiana recently adopted a law that could wipe out the e-liquid industry in that state and, if not taken off the books permanently, could create dangerous precedent for other states.  Effective July 2016, the law prohibits e-liquid manufacturers, whether or not they are located in the state, from selling products to retailers and distributors in Indiana without a permit which requires compliance with expensive and burdensome manufacturing and security protocols that may be impossible to meet. Indiana vape shops will also be required to obtain a tobacco sales certificate and are prohibited from selling e-liquids where the manufacturer has failed to obtain a permit.  Of most concern, the statute is aimed solely at e-liquids used in “open-system” products, while giving manufacturers of “closed-system” cigalikes a free pass.

Three e-liquid producers and an Indiana vape shop recently filed a lawsuit in federal district court challenging the statute on various constitutional grounds.  Because it is absolutely critical for the court to understand that this statute poses a substantial risk to the entire e-vapor industry, as well as for an industry-wide association to take charge of advocacy efforts across the country, The premium e liquid company Cosmic Fog Vapors came together with Vapor Shark and Mt. Baker Vapor to form the Right to be Smoke-Free Coalition.

On May 24, 2016 the companies working with the Mulhaupt’s security firm filed a Motion to Intervene in our case and argued that we, the plaintiffs, be required to post a bond in case our preliminary injunction is granted. A similar motion was made by the permit holders in the parallel state court case filed by Hoosier Vapers. (In that case, the state court granted the permit holders’ motion to intervene and denied Hoosier Vaper’s motion for preliminary injunction, which made the bond request moot.)

In our response, we argue that the permit holders failed to satisfy the requirements necessary to intervene in our case because (1) they rely on unsupported, vague and conclusory allegations, (2) they did not comply with the procedural requirements to intervene pursuant to the Federal Rules of Civil Procedure, (3) their efforts are untimely, (4) they lack a cognizable legal interest to intervene, including the fact that the purposes underlying a bond requirement do not exist here, (5) we, the Right to be Smoke Free Coalition, will be substantially prejudiced, and (6) the State of Indiana has adequately represented the permit holders’ interests in this case. Instead, we make clear for the court that the permit holders seek to intervene for the inappropriate purpose of preventing us from exercising our constitutional rights and to make us post a bond because they chose to comply with an unconstitutional regulatory scheme, even though they were well aware of our lawsuit.

We are hopeful that the judge will deny their motion to intervene and grant our preliminary injunction, preventing the law from going into effect on July 1. We will keep you updated.

R2B Members

premium e liquid
Rob Crossley

Director and President

ecig box mod
Brian Walters

Director and Secretary

e liquid manufacturing
Kenny Davis

Director and Treasurer

Scott Eley


Nick Gollust


Alena and Greg Oberg


Cheryl and Tony Reed




Evan McMahon


Steve Nair


Allen Joseph


Jonathon Lee


Schell Hammel


Steve and Sharla Belcher


Vicki Vasconcellos


Max Sobol


Chris Hughes


Rob Fitzgerald


Michelle Foster


Patrick Mulcahy


Matthew Halvorson